Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:53 pm Purchase | 2022-12-31 | 13G | Angion Biomedica Corp. ANGN | Thomas A. Satterfield, Jr. | 221,338 7.350% | 63,884 (+40.57%) | Filing History |
| 2022-05-19 10:04 am Purchase | 2022-05-17 | 13G | Angion Biomedica Corp. ANGN | Thomas A. Satterfield, Jr. | 157,455 5.300% | 157,455 (New Position) | Filing History |
| 2022-04-27 4:10 pm Sale | 2021-12-31 | 13G | Angion Biomedica Corp. ANGN | Elicio Therapeutics Inc. ELTX | 181,512 6.000% | -108,662 (-37.45%) | Filing History |
| 2022-04-27 4:08 pm Purchase | 2021-02-04 | 13D | Angion Biomedica Corp. ANGN | Elicio Therapeutics Inc. ELTX | 290,174 9.300% | 290,174 (New Position) | Filing History |
| 2022-03-30 3:51 pm Purchase | 2021-02-09 | 13G | Angion Biomedica Corp. ANGN | Vifor (International) Ltd. | 199,564 6.700% | 199,564 (New Position) | Filing History |
| 2022-02-14 5:29 pm Purchase | 2021-12-31 | 13G | Angion Biomedica Corp. ANGN | EISA-ABC LLC | 172,224 5.700% | 172,224 (New Position) | Filing History |